Federal contract award
HHSN272201400008C
IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541711 |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $79.7M |
| Current contract value | $79.7M |
| Potential contract value / ceiling | $182.0M |
| Start date | Jan 9, 2014 |
| Current end date | Aug 1, 2022 |
| Potential end date | May 24, 2023 |
| Latest award activity | Aug 27, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 43 of 43 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 27, 2026 | P00042 | $-56.3K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Sep 22, 2025 | P00041 | $-199.3K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| May 8, 2024 | P00040 | $-24.5K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Apr 1, 2024 | P00039 | $-21.0K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Aug 1, 2022 | P00037 | $-27.8K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Aug 1, 2022 | P00038 | $-40.3K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Mar 14, 2022 | P00036 | $0 | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Oct 12, 2021 | P00035 | $0 | EO14042 - NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| May 19, 2021 | P00034 | $1.8M | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Apr 8, 2021 | P00033 | $308.0K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Mar 17, 2021 | P00032 | $-189.4K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Dec 15, 2020 | P00031 | $-104.2K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Aug 21, 2020 | P00030 | $0 | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Jul 28, 2020 | P00029 | $738.2K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Jun 26, 2020 | P00028 | $423.8K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Jun 16, 2020 | P00027 | $1.4M | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| May 22, 2020 | P00026 | $2.3M | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| May 4, 2020 | P00025 | $1.2M | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Apr 21, 2020 | P00024 | $423.8K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Mar 23, 2020 | P00023 | $7.9M | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Sep 10, 2019 | P00022 | $3.5M | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Jul 2, 2019 | P00021 | $1.3M | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Jun 12, 2019 | P00020 | $1.3M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| May 2, 2019 | P00019 | $-53.0K | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Apr 15, 2019 | P00018 | $6.5M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Mar 29, 2019 | P00017 | $0 | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Sep 14, 2018 | 16 | $6.8M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTIONS, REVISE NON-SEVERABLE OPTION END DATES, MAKE EQUITABLE ADJUSTMENTS, AND UPDATE VARIOUS CLAUSES AND ARTICLES. |
| Mar 19, 2018 | 15 | $6.9M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION 4, OPTION 10A AND OPTION 17, REMOVE THE FISMA REQUIREMENTS OF ARTICLE H.21, AND UPDATE NEW CONTRACTING OFFICERS REPRESENTATIVE (COR). |
| Aug 18, 2017 | 14 | $2.5M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Jul 25, 2017 | 13 | $2.3M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Mar 14, 2017 | 12 | $6.5M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Sep 23, 2016 | 11 | $2.7M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Sep 8, 2016 | 10 | $1.1M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Mar 14, 2016 | 9 | $6.1M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Mar 9, 2016 | 8 | $0 | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Aug 25, 2015 | 7 | $1.2M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Jul 17, 2015 | 5 | $0 | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Jul 17, 2015 | 6 | $296.6K | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Jul 15, 2015 | 4 | $-296.6K | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| May 18, 2015 | 3 | $515.1K | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Mar 18, 2015 | 2 | $6.3M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Sep 11, 2014 | 1 | $2.3M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Jan 9, 2014 | 0 | $6.0M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.